Has Rajesh Bajpai, MD received payments from drug or device companies?

Yes. Drug and device makers reported $22,429 in general payments to Rajesh Bajpai, MD across 33 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Rajesh Bajpai, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Rajesh Bajpai, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Rajesh Bajpai, MD

Urology · Somerset, PANPI 1457902900

Payments from drug & device makers

What this record shows

This record is dominated by grants: $20,000 of the $22,429 with a category attached, or 89.2%. Boston Scientific accounts for 89.5% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2020 at $20,550 and has fallen 99.0% since, to $201 in 2025. Among urology clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$22,429in general payments, 2019–2025

Across 33 payments — averaging $679.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$20K
Cook Incorporated$829
Metuchen Pharmaceuticals$244
Cook Medical LLC$218
Coloplast$214
Profound Medical Corp.$201
plus $657 from 13 others

What the payments were for

Grants$20,00089%
Travel & lodging$8294%
Food & beverage$1,5997%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	3	$20,066
Cook Incorporated	2	$829
Metuchen Pharmaceuticals	4	$244
Cook Medical LLC	2	$218
Coloplast	2	$214
Profound Medical Corp.	1	$201
Smith+Nephew	5	$156
Procept Biorobotics Corporation	1	$146
Olympus America Inc.	2	$76
Myovant Sciences Inc.	2	$60
Foundation Medicine, Inc.	1	$46
Koelis Inc.	1	$32
Sumitomo Pharma America, Inc.	1	$26
Merck	1	$23
Johnson & Johnson	1	$23
Biotissue Holdings Inc.	1	$21
Pfizer	1	$19
Angiodynamics, Inc.	1	$17
C. R. Bard, Inc. & Subsidiaries	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$22,429 in reported general payments places this provider in the 90th percentile of 596 urology providers in Pennsylvania.

See all urology providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$96,629

Medicare patients

218

Services billed

909

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
MyrbetriqMirabegron	42	$20,053
Mirabegron ErMirabegron	20	$11,510
Tamsulosin Hcl	400	$5,413
Methenamine Hippurate	53	$2,320
Finasteride	102	$1,383
Oxybutynin Chloride	113	$1,032
Potassium Citrate ErPotassium Citrate	23	$926
CefuroximeCefuroxime Axetil	77	$755
Oxybutynin Chloride ErOxybutynin Chloride	28	$507
Levofloxacin	249	$487
Alfuzosin Hcl ErAlfuzosin Hcl	18	$357
Doxycycline Hyclate	28	$205

Paid to pharmacies, not to this prescriber.

Other urology in Somerset

John AndersonBethlehem$2.1M
Demetrius BagleyPhiladelphia$739K
Paul SieberLancaster$631K
Daniel EunPhiladelphia$226K
Leonard GomellaPhiladelphia$190K
Anthony DimatteoButler$189K
Angelo BaccalaAllentown$166K
Phillip GinsbergPhiladelphia$145K
Edouard TrabulsiPhiladelphia$137K
Siobhan HartiganPhiladelphia$121K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →